Conditions: Cataract Inflammation Surgery
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 369
Healthy volunteers: no

Brief summary:
The objective of this clinical study is to compare the safety and efficacy of mapracorat ophthalmic suspension, 3% with its vehicle for the treatment of postoperative inflammation and pain following cataract surgery.

Detailed description:

Arms:
arm 1: Mapracorat ophthalmic suspension, 3%, arm 2: The vehicle of the mapracorat ophthalmic suspension

Interventions: intervention 1: Mapracorat intervention 2: Placebo
Intervention descriptions: intervention 1: 1 drop of study medication into the study eye QID for 14 days intervention 2: 1 drop of vehicle into the study eye QID for 14 days.

Protocol document: